US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 776.050
  • -7.120-0.91%
Trading Dec 30 13:54 ET
736.72BMarket Cap83.90P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eli Lilly and Co Q3 2024 Earnings Date

Overview | Lilly reported revenue of $11.4 billion, a 20% year-over-year increase, along with earnings per share (EPS) of $1.18, which fell short of Wall Street estimates

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
12.12B
11.44B
-679.50M
Miss Est.
+27.58%
+20.43%
-5.61%
EPS
1.54
1.07
-0.47
Miss Est.
+2677.80%
+1883.33%
-30.70%
Analyst Rating
Strong Buy

Dec 20, 2024

Eli Lilly and Co Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.977B--
--2024/Q4-- / 13.981B--
Oct 30, 20242024/Q311.439B / 12.119B--
Aug 8, 20242024/Q211.303B / 9.968B--
Apr 30, 20242024/Q18.768B / 8.930B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.977B--
--2024/Q4-- / 13.981B--
Oct 30, 20242024/Q311.439B / 12.119B--
Aug 8, 20242024/Q211.303B / 9.968B
Eli Lilly Q2 2024 earnings conference call
Aug 8 09:00
Replay
Apr 30, 20242024/Q18.768B / 8.930B--

Unlock Free Earnings Estimates

Eli Lilly and Co Earnings Reports

  • Eli Lilly and Co | 10-Q: Q3 2024 Earnings Report

    Oct 30 11:57 ET

  • Eli Lilly and Co | 10-Q: Q2 2024 Earnings Report

    Aug 8 11:34 ET

  • Eli Lilly and Co | 10-Q: Q1 2024 Earnings Report

    Apr 30 12:09 ET

  • Eli Lilly and Co | 10-K: FY2023 Annual Report

    Feb 21 11:46 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +6.08%
    Precision Drilling
    PDS
    +3.74%
    New Fortress Energy
    NFE
    +2.21%
    Hutchmed (China)
    HCM
    +0.63%
    Enerpac Tool
    EPAC
    +0.31%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 20, 2024

    Strong Buy

    • Buy

      90.48%

    • Hold

      9.52%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday-0.93%